Inspired by AHA PREVENT™ and PHRI Research Results

1-Minute Cardiovascular Risk Assessment

Understand your cardiovascular health in 1 minute. No blood test required for our quick assessment mode.

If you find this useful, please star it on GitHub! 🚀
star-this-project

Contact me through Social Media or Email

Health & Lifestyle Questionnaire
Please answer the following questions to estimate your CVD risk. No blood test required.
Your Heart Risk Result
0.7%
Low Risk

Estimated CVD risk for 5-year window based on NL-IHRS validated algorithms.

• Based on Non-Laboratory INTERHEART Risk Score.

• Calculated specifically for the Overall Average region.

• This is a screening tool, not a medical diagnosis.

How is your result calculated?

Both calculators on this site reproduce peer-reviewed, externally-validated risk equations — not simplified approximations. Below we explain exactly which formulas are used, where they come from, and why you can trust the output.

This calculator is a faithful replication of the Non-Laboratory INTERHEART Risk Score (NL-IHRS), given website developer's technical ability, as externally validated in the PURE (Prospective Urban Rural Epidemiology) study — a community-based prospective cohort of over 140 000 participants across 17 countries and 7 geographic regions.

The underlying research was led by Dr Philip Joseph (first author, Population Health Research Institute, McMaster University, Hamilton, Canada — a cardiologist and clinical trialist whose work focuses on global cardiovascular epidemiology) and Professor Salim Yusuf (senior / corresponding author, McMaster University — one of the most cited cardiovascular researchers in the world, principal investigator of the landmark INTERHEART, PURE, and HOPE trials, and a recipient of the Order of Canada). The validation cohort spans high-, middle-, and low-income countries, making the score uniquely suited for diverse populations.

Our implementation faithfully reproduces the Prognostic Index (PI) for a given set of risk-factor point totals using the original INTERHEART regression coefficients published in the paper:

Equation [3] — Estimated Prognostic Index from total points:

estimated PI = −1.45 + 0.2875 × (NL-IHRS total points / 2)

Region-specific recalibration is then applied using the intercept (α̂) and slope (β̂) measured in each PURE region (Table 2 of the paper), producing the final predicted probability:

Equation [4] — Recalibrated CVD risk:

p̂ = 1 / { 1 + exp[ −( α̂ + β̂ × estimated PI ) ] }

Following recalibration, the score achieved a C-statistic of 0.72 (95 % CI 0.71–0.73) in the overall PURE population — moderate-to-good discrimination across all seven regions — and was only marginally outperformed by the laboratory-based FC-IHRS (C-statistic 0.74 vs 0.73, p < 0.001).

References

Joseph P, Yusuf S, Lee SF, et al. Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world. Heart 2018;104:581–587. doi:10.1136/heartjnl-2017-311609.

This calculator is based on/faithfully reproduces(100% replication not garuanteed), given website developer's technical ability, the American Heart Association's Predicting Risk of cardiovascular disease EVENTs (PREVENT™) equations, which estimate 10-year and 30-year absolute risk for total CVD, atherosclerotic CVD (ASCVD), and heart failure (HF) among adults aged 30–79 years.

The PREVENT™ equations were developed by select members of the American Heart Association Cardiovascular-Kidney-Metabolic Scientific Advisory Group. The risk equations were derived and validated in a large, diverse sample of over 6 million individuals. Our implementation reproduces the published coefficients and model structure, including the base model and optional enhanced models incorporating UACR (urine albumin-to-creatinine ratio), HbA1c, and SDI (Social Deprivation Index).

The 2025 AHA/ACC High Blood Pressure Guideline recommends the PREVENT-CVD equations to inform management decisions for Stage 1 hypertension (10-year CVD risk ≥ 7.5 % threshold), and the 2026 ACC/AHA Dyslipidemia Guideline recommends the PREVENT-ASCVD equations to guide lipid-lowering therapy, categorizing risk as low (< 3 %), borderline (3–< 5 %), intermediate (5–< 10 %), or high (≥ 10 %).

The information derived from the use of PREVENT™ is based on PREVENT™ 1.0.0. Updates and future adaptations of PREVENT™ may yield different results and conclusions.

References

  1. Khan SS, Matsushita K, Sang Y, et al. Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT™) Equations. Circulation 2023. DOI: 10.1161/CIRCULATIONAHA.123.067626.
  2. Khan SS, Coresh J, Pencina MJ, et al. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation 2023;148(24):1982-2004. DOI: 10.1161/CIR.0000000000001191.

This tool is intended to support clinician–patient discussions. It is not a diagnostic instrument and should not be used to make independent treatment decisions. Patients should discuss their risk information with their clinician.

Medical Disclaimer

This tool is for educational and academic demonstration purposes only. It is not a diagnostic tool and does not replace professional medical advice. Always consult a physician for health-related decisions. The results provided are estimates based on statistical models and population averages.

© 2026 HeartEase Predictor

Professional Mode (PREVENT™) is based in part on equations developed by the American Heart Association. PREVENT™ is not a diagnostic tool.